Janux

Janux is a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies.

Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2021
Stage of Initial Investment
Series A
Initial Investment Year
2021
Janux Hover Image